New obesity drug tested in teens – early safety results in
NCT ID NCT07143227
First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 33 times
Summary
This early-stage study tested an investigational drug called XW003 in 48 Chinese teenagers with obesity. The main goal was to check safety and how the drug moves through the body, while also measuring weight changes. Participants received multiple doses of the drug or a placebo, and the study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
Conditions
Explore the condition pages connected to this study.